OCTA Study of Choroidal Vasculature in Open Angle Glaucoma Patients

Glaucoma Open-Angle Primary Clinical Trial

Official title:
OCTA as a New Biomarker in the Pathogenesis of Primary Open Angle Glaucoma

Status Completed

Clinical Trial Summary

The aim of the present study was to examine and measure SFCT and CCVD using respectively EDI-OCT and OCTA in preperimetric and advanced glaucomatous eyes, in order to shed light on the vascular pathogenesis of glaucoma disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05455567
Study type	Observational
Source	Federico II University
Contact
Status	Completed
Phase
Start date	February 1, 2022
Completion date	May 15, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03310788` - Monitoring of the IOP After SLT Using iCare Home
Terminated	`NCT03875911` - Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy	Phase 4
Not yet recruiting	`NCT04295122` - Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for Glaucoma Patients	Phase 4
Completed	`NCT04727411` - Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes	N/A
Recruiting	`NCT05913232` - Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension	Phase 2